Literature DB >> 24210163

Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Andrea Schietinger1, Philip D Greenberg2.   

Abstract

CD8 T cell activation and differentiation are tightly controlled, and dependent on the context in which naïve T cells encounter antigen, can either result in functional memory or T cell dysfunction, including exhaustion, tolerance, anergy, or senescence. With the identification of phenotypic and functional traits shared in different settings of T cell dysfunction, distinctions between such dysfunctional states have become blurred. Here, we discuss distinct states of CD8 T cell dysfunction, with an emphasis on: (i) T cell tolerance to self-antigens (self-tolerance); (ii) T cell exhaustion during chronic infections; and (iii) tumor-induced T cell dysfunction. We highlight recent findings on cellular and molecular characteristics defining these states, cell-intrinsic regulatory mechanisms that induce and maintain them, and strategies that can lead to their reversal.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD8 T cells; T cell differentiation; T cell dysfunction; chronic infection; exhaustion; self-tolerance; tumors

Mesh:

Year:  2013        PMID: 24210163      PMCID: PMC3946600          DOI: 10.1016/j.it.2013.10.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  121 in total

Review 1.  Mechanisms maintaining peripheral tolerance.

Authors:  Daniel L Mueller
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 2.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity.

Authors:  Kajsa Wing; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

3.  Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.

Authors:  Hyun-Tak Jin; Ana C Anderson; Wendy G Tan; Erin E West; Sang-Jun Ha; Koichi Araki; Gordon J Freeman; Vijay K Kuchroo; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

5.  Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Authors:  Junko Matsuzaki; Sacha Gnjatic; Paulette Mhawech-Fauceglia; Amy Beck; Austin Miller; Takemasa Tsuji; Cheryl Eppolito; Feng Qian; Shashikant Lele; Protul Shrikant; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

6.  Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation.

Authors:  Lisa D S Johnson; Stephen C Jameson
Journal:  J Immunol       Date:  2010-04-14       Impact factor: 5.422

Review 7.  Features of responding T cells in cancer and chronic infection.

Authors:  Peter S Kim; Rafi Ahmed
Journal:  Curr Opin Immunol       Date:  2010-03-06       Impact factor: 7.486

Review 8.  Epigenomics of T cell activation, differentiation, and memory.

Authors:  Suresh Cuddapah; Artem Barski; Keji Zhao
Journal:  Curr Opin Immunol       Date:  2010-03-11       Impact factor: 7.486

9.  Irradiation and IL-15 promote loss of CD8 T-cell tolerance in response to lymphopenia.

Authors:  Thilo Oelert; Maria Papatriantafyllou; Georg Pougialis; Günter J Hämmerling; Bernd Arnold; Thomas Schüler
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113

Review 10.  HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.

Authors:  Giuseppe Castello; Stefania Scala; Giuseppe Palmieri; Steven A Curley; Francesco Izzo
Journal:  Clin Immunol       Date:  2009-11-11       Impact factor: 3.969

View more
  256 in total

1.  Immunomodulatory glc/man-directed Dolichos lablab lectin (DLL) evokes anti-tumour response in vivo by counteracting angiogenic gene expressions.

Authors:  V Vigneshwaran; P Thirusangu; B R Vijay Avin; V Krishna; S N Pramod; B T Prabhakar
Journal:  Clin Exp Immunol       Date:  2017-04-05       Impact factor: 4.330

2.  Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.

Authors:  Edmund K Moon; Raghuveer Ranganathan; Evgeniy Eruslanov; Soyeon Kim; Kheng Newick; Shaun O'Brien; Albert Lo; Xiaojun Liu; Yangbing Zhao; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2015-08-31       Impact factor: 12.531

Review 3.  IFN-γ: A cytokine at the right time, is in the right place.

Authors:  J Daniel Burke; Howard A Young
Journal:  Semin Immunol       Date:  2019-06-17       Impact factor: 11.130

4.  Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Authors:  Kristen E Pauken; Christine E Nelson; Tijana Martinov; Vaiva Vezys; Brian T Fife; Justin A Spanier; James R Heffernan; Nathanael L Sahli; Clare F Quarnstrom; Kevin C Osum; Jason M Schenkel; Marc K Jenkins; Bruce R Blazar
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

5.  Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.

Authors:  Andrea Schietinger; Mary Philip; Varintra E Krisnawan; Edison Y Chiu; Jeffrey J Delrow; Ryan S Basom; Peter Lauer; Dirk G Brockstedt; Sue E Knoblaugh; Günter J Hämmerling; Todd D Schell; Natalio Garbi; Philip D Greenberg
Journal:  Immunity       Date:  2016-08-09       Impact factor: 31.745

6.  Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens.

Authors:  Aaron M Miller; Milad Bahmanof; Dietmar Zehn; Ezra E W Cohen; Stephen P Schoenberger
Journal:  Cancer Immunol Res       Date:  2018-11-27       Impact factor: 11.151

Review 7.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

Review 8.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

Review 9.  Self-reactivity as the necessary cost of maintaining a diverse memory T-cell repertoire.

Authors:  Nevil J Singh
Journal:  Pathog Dis       Date:  2016-09-11       Impact factor: 3.166

10.  OMIP-036: Co-inhibitory receptor (immune checkpoint) expression analysis in human T cell subsets.

Authors:  Zachary R Healy; David M Murdoch
Journal:  Cytometry A       Date:  2016-09-13       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.